We are an innovative Biopharmaceutical company based in the Seattle area that focuses on improving the efficacy, safety, development risk, and speed-to-market of injectable peptides and proteins (biologics) for the treatment of Ascites, Auto-Immune diseases and others. Our revenue model is based on molecule/territory based exclusive licensing and technology access deals with corporate partners, in return for milestone and royalty payments.